Free Trial

Kooth (KOO) Competitors

Kooth logo
GBX 158 0.00 (0.00%)
As of 10:53 AM Eastern

KOO vs. INS, RENX, COG, INHC, FDBK, IQAI, TRLS, DVRG, SENS, and EMIS

Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.

Kooth vs. Its Competitors

Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

In the previous week, Kooth's average media sentiment score of 0.67 beat Instem's score of 0.00 indicating that Kooth is being referred to more favorably in the media.

Company Overall Sentiment
Kooth Positive
Instem Neutral

Kooth has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500.

Kooth currently has a consensus target price of GBX 456.67, suggesting a potential upside of 189.03%. Given Kooth's stronger consensus rating and higher possible upside, equities research analysts clearly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kooth
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

26.9% of Kooth shares are owned by institutional investors. Comparatively, 65.9% of Instem shares are owned by institutional investors. 30.9% of Kooth shares are owned by company insiders. Comparatively, 30.0% of Instem shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Kooth has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kooth£66.74M0.85£4.00M£0.21752.38
Instem£61.63M0.00£3.34M£0.14N/A

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 18.59% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Kooth7.89% 18.59% 10.12%
Instem 5.50%6.35%4.62%

Summary

Kooth beats Instem on 12 of the 14 factors compared between the two stocks.

Get Kooth News Delivered to You Automatically

Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£56.47M£342.27M£5.71B£2.61B
Dividend YieldN/A5.89%6.66%5.34%
P/E Ratio752.38513.3283.105,164.17
Price / Sales0.85230.76544.9198,067.78
Price / Cash5.4247.1425.6627.93
Price / Book2.455.0911.767.36
Net Income£4.00M-£15.55M£3.27B£5.89B
7 Day PerformanceN/A-0.88%1.13%0.71%
1 Month Performance-0.11%1.25%8.30%45.99%
1 Year Performance-51.53%7.14%62.26%181.68%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
1.7 of 5 stars
GBX 158
flat
GBX 456.67
+189.0%
-51.5%£56.47M£66.74M752.38478
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
RENX
Renalytix
N/AGBX 5.62
-2.3%
N/A-49.3%£23.28M£9.22M-0.27102Gap Down
COG
Cambridge Cognition
N/AGBX 27
+3.8%
N/A-26.7%£11.30M£15.64M-7.1880News Coverage
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A+14.7%£9.00M£12.57M-1.7674
FDBK
Feedback
N/AGBX 13.19
-0.5%
N/A-76.0%£5.78M£3.88M-0.5324
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-32.8%£1.77M£538.19K-13.676Gap Up
TRLS
Trellus Health
N/AGBX 0.62
-12.1%
N/A-49.6%£1.19M£65.83K-0.1831Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools


This page (LON:KOO) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners